Shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) ended Tuesday session in green amid volatile trading. The shares closed up +0.11 points or 0.21% at $51.33 with 1.01 billion shares getting traded. Post opening the session at $51.26, the shares hit an intraday low of $51.04 and an intraday high of $51.80 and the price vacillated in this range throughout the day. The company has a market cap of $52.49 billion and the numbers of outstanding shares have been calculated to be 1.01 billion shares.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) announced that it will host a live audio webcast at the Wells Fargo Healthcare Conference. Eyal Desheh will present on Wednesday, September 7, 2016 at 1:10 PM ET.
What: Teva Presentation at the Wells Fargo 2016 Healthcare Conference
Eyal Desheh, Group EVP & CFO
Teva Pharmaceutical Industries Ltd.
When: Wednesday, September 7, 2016
How: Live over the Internet – log on to the Web at the address above and register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva’s website.
Shares of HCA Holdings Inc (NYSE:HCA) ended Tuesday session in red amid volatile trading. The shares closed down -0.36 points or -0.47% at $76.15 with 378.65 million shares getting traded. Post opening the session at $76.25, the shares hit an intraday low of $74.94 and an intraday high of $76.28 and the price vacillated in this range throughout the day. The company has a market cap of $29.38 billion and the numbers of outstanding shares have been calculated to be 378.65 million shares.
HCA Holdings Inc (HCA) on September 7, 2016 announced the signing of an agreement to purchase Mobile Heartbeat, a leading developer of applications for smartphones to improve clinical workflow and team communications. Mobile Heartbeat technology solutions consolidate clinical communications, including alarms and notifications, patient information and lab data, secure texting, voice and photography.
HCA recently completed a successful pilot of Mobile Heartbeat’s CURE™ (Clinical Urgent Response) technology for its iMobile Project, an initiative to implement smartphone-based critical care team communications. HCA is launching Mobile Heartbeat’s CURE technology in 21 hospitals across the country with plans to implement the technology enterprise-wide.
“Mobile Heartbeat is an innovator that is keenly focused on meeting the mobile technology needs of clinicians,” said Dr. Jonathan Perlin, HCA’s chief medical officer and president of the Clinical Services Group. “This acquisition will enhance our ability to work closely with Mobile Heartbeat as we continue to create and refine technology solutions to improve clinical workflows and provide secure communications that foster better patient care.”
Following the completion of the transaction, Mobile Heartbeat’s current chief executive officer Ron Remy will serve as CEO of the organization which will operate as an indirect, wholly owned subsidiary of HCA. Mobile Heartbeat’s team will continue to serve the company’s clients and market its products to leading healthcare organizations from the company’s location in Massachusetts.
“We’ve worked closely with HCA for several years to better understand the challenges clinicians face and to enhance our applications to meet their needs,” said Remy. “Joining HCA will help us serve our current and future customers through a closer collaboration with one of the leading healthcare providers in the world. HCA’s leadership will be instrumental as we continue to develop improved solutions for secure clinical communications.”